More on Flexion Q2 results


Flexion Therapeutics (FLXN +1.6%) Q2 results: Revenues: $0; Net Loss: ($5.9M) (-29.0%); Loss Per Share: ($0.38) (+93.5%); Quick Assets: $72.0M (+339.0%).

No financial guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs